Lushang Freda PharmaceuticalLtd Dividende
Dividende contrôle des critères 2/6
Lushang Freda PharmaceuticalLtd is a dividend paying company with a current yield of 1.47% that is well covered by earnings.
Informations clés
1.5%
Rendement du dividende
-0.3%
Rendement des rachats
| Rendement total pour l'actionnaire | 1.2% |
| Rendement futur des dividendes | 2.3% |
| Croissance des dividendes | 5.5% |
| Prochaine date de paiement du dividende | n/a |
| Date ex-dividende | n/a |
| Dividende par action | CN¥0.100 |
| Ratio de distribution | 63% |
Mises à jour récentes des dividendes
Pas de mise à jour
Recent updates
Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Doing What It Can To Lift Shares
Jun 21
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)
Feb 27Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: 600223 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Dividende croissant: 600223's dividend payments have increased, but the company has only paid a dividend for 5 years.
Rendement des dividendes par rapport au marché
| Lushang Freda PharmaceuticalLtd Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (600223) | 1.5% |
| 25% du marché (CN) | 0.6% |
| 25% du marché (CN) | 2.2% |
| Moyenne du secteur (Real Estate) | 2.3% |
| Analyste prévisionnel (600223) (jusqu'à 3 ans) | 2.3% |
Dividende notable: 600223's dividend (1.47%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Dividende élevé: 600223's dividend (1.47%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Bénéfice distribué aux actionnaires
Couverture des revenus: With its reasonable payout ratio (62.8%), 600223's dividend payments are covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: With its high cash payout ratio (179.7%), 600223's dividend payments are not well covered by cash flows.